Acomplia is also known as rimonabant, which is an anti-obesity drug. Acomplia (rimonabant) is the first in a new class of therapeutic agents which is called Cannabinoid-1 Receptor Blockers (CB1). The drug is used in the treatment of obesity and related conditions.

Acomplia works as appetite suppressant. Acomplia contains Rimonabant as the active ingredient which acts as a cannabinoid type I (CB1) receptor and works in the brain to produce feelings of fullness even by eating less food. This is the used system to govern energy balance, glucose and lipid metabolism as well as body weight. Within the brain these CB1 receptors are make up part of a system know as the metabolism system which regulates our intake of highly palatable, fatty or sweet foods. With these receptors blocked and further over action prevented not only do patient’s experience the benefits of appetite suppression but also an increase in metabolism and energy which would usually be reduced when using a weight loss program alone.

First thing you should do is consult a doctor. It is very easy to get carried away with the belief that you can lose weight on your own by dieting and exercising. By consulting a doctor, you can know exactly where you stand, and which medicine would be good for your weight reduction program.

Acompila is working internally different from Xenical and Reductil. Acomplia differs from the other two obesity treatments currently available in the UK, Xenical and Reductil, as it is the only one of these treatments to directly target the encannbinoid system. This means that not does Acomplia work well at suppressing appetite but it is also efficient at maintaining a patient’s metabolic rate.